A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in a 26-Year-Old Pregnant Woman

Natalie Shaykh1, Falguni Patel1, Luke Stachler1

  • 1Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.

Cureus
|June 21, 2024
PubMed

Insights

Acute lymphoblastic leukemia (ALL) is a rare blood cancer. This case highlights a multidisciplinary treatment approach for Philadelphia chromosome-positive ALL (Ph+ ALL) in an adult patient from a unique demographic.

Area of Science:

  • Hematology
  • Oncology

Background:

  • Acute lymphoblastic leukemia (ALL) is a rare, aggressive blood cancer originating in bone marrow, marked by immature lymphocyte overgrowth.
  • While common in children, ALL presents bimodal peaks, affecting early childhood and individuals around age 50.
  • Cytogenetic abnormalities, notably the Philadelphia chromosome (Ph), are present in 20-33% of adult ALL cases.

Observation:

  • This case report focuses on a patient diagnosed with Philadelphia chromosome-positive ALL (Ph+ ALL).
  • The patient's demographic profile is unique, presenting atypical characteristics for this subtype of leukemia.
  • The study emphasizes the critical role of a multidisciplinary approach in managing this complex condition.

Findings:

  • The case underscores the effectiveness of a comprehensive, team-based strategy in treating Ph+ ALL.
  • Treatment tailored to the patient's unique characteristics and disease profile yielded positive outcomes.
  • Integration of various medical specialties was crucial for optimal patient management.

Implications:

  • This case provides valuable insights into managing Ph+ ALL in specific patient populations.
  • It highlights the importance of personalized medicine and multidisciplinary collaboration in hematologic oncology.
  • The findings may inform future treatment protocols for adult Ph+ ALL, particularly in unique demographic groups.